Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05619172
Title A Study of Nanrilkefusp Alfa (SOT101) in Combination With Cetuximab to Evaluate the Efficacy and Safety in Patients With Colorectal Cancer
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors SOTIO Biotech AG
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA | ESP | BEL

Facility Status City State Zip Country Details
Grand Hopital de Charleroi - Hopital Notre Dame Charleroi 6000 Belgium Details
Universitair Ziekenhuis Gent Gent 9000 Belgium Details
Institut Bergonié Bordeaux 33076 France Details
Hopital Foch Suresnes 92150 France Details
Vall d'Hebron Institut d'Oncologia (VHIO) Barcelona 08035 Spain Details
Hospital Clinic de Barcelona Barcelona 08036 Spain Details
Hospital Universitario Ramón y Cajal Madrid 28034 Spain Details
HM Universitario Sanchinarro Madrid 28050 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field